Proven
neurotechnology
built for the
real world
Control Bionics delivers objective, non-invasive neural-signal technology, proven in clinical environments, and built to scale across performance, rehabilitation, medical, research, and assistive communication.
Proven
neurotechnology
built for the
real world
Control Bionics delivers objective, non-invasive neural-signal technology, proven in clinical environments, and built to scale across performance, rehabilitation, medical, research, and assistive communication.
Capability
From signal to actionable insight
The Control Bionics neural-signal platform captures physiological data with medical-grade precision and converts it into measurable, decision-ready outcomes. Built for deployment across clinical, research, and performance environments — and validated where it counts.
Signal acquisition and processing
Real-time analysis and validation
Clinical integration and reporting
Technology
The platform serves distinct markets with precision and measurable outcomes. One underlying technology - four applications.
A platform built for clinical deployment
Medical-grade signal processing meets real-world clinical environments. Designed for integration, validation, and measurable outcomes.
Non-invasive neural signal capture
Physiological data without surgical intervention or implantation. Validated for use in complex clinical environments.
Regulatory pathway established
Cleared for clinical use with ongoing validation across multiple applications — FDA, TGA, and CE registered.
Outcome-focused architecture
Platform designed to deliver decision-ready insights, not only raw data. Built to integrate into clinical and research workflows.
Evidence from clinical and research deployment
Control Bionics technology is validated through research, clinical trials, and real-world deployment across rehabilitation, performance, and research settings.
1,000s of users
Trusted by individuals, clinicians, and organisations across four markets
Government and privately funded
Approved for funding through Medicare, Medicaid, NDIS, and private insurance pathways.
100%
Non-invasive signal acquisition
3 Regulatory clearances
(FDA, TGA, CE)
Latest from our platform
Research, clinical validation and platform developments.
The ALS Association awards a prestigious Assistive Technology Grant to Control Bionics
Control Bionics is thrilled to announce it has been awarded one of the prestigious ALS Association 2023 Assistive Technology Grants. The ALS Association is the leading ALS organization in the world and is working to make ALS a livable disease while urgently searching...
Community Resource: Medical Page for Grid3
Alex Knight, avid concert-goer and 29 year old Floridian living with Cerebral Palsy, gives us her honest review of making a grid set. See what she has to say and download her grid set!
Introducing Control Bionics Champion, Max Bailey
Introducing Max Bailey-Jensen! Max's unwavering determination and use of assistive technologies have allowed him to defy his disability and strive towards Olympic participation. His remarkable journey serves as an inspiration, showcasing the power of resilience and...
Myth V Fact Series #1
There are always myths that surround products in the technology world. Especially technology like the Neuro Node often finds itself surrounded by myths and misconceptions. In this blog series we will go through some of the myths we have heard about the Neuro Node and...
Select your path to neural-signal insights and outcomes
Explore how the platform integrates into clinical workflows and delivers decision-ready outcomes.
Learn more
Discover how researchers are using real-time neural data to power breakthrough studies.
LearnNDIS-registered provider
Control Bionics is a registered NDIS provider. Eligible participants can access our assistive communication devices and neurotechnology solutions through their NDIS plan.